Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishnu C Ramani

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|February 3, 2012
Heparan sulfate chains of syndecan-1 regulate ectodomain sheddingVishnu C Ramani, Pamela S Pruett, Camilla A Thompson, et al.
Cancer Research|October 28, 2010
Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKLYang Yang, Yongsheng Ren, Vishnu C Ramani, et al.
Oncotarget|December 2, 2015
Targeting heparanase overcomes chemoresistance and diminishes relapse in myelomaVishnu C Ramani, Fenghuang Zhan, Jianbo He, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 27, 2016
Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotypeVishnu C Ramani, Israel Vlodavsky, Mary Ng, et al.
The FEBS Journal|February 5, 2013
The heparanase/syndecan-1 axis in cancer: mechanisms and therapiesVishnu C Ramani, Anurag Purushothaman, Mark D Stewart, et al.
Blood Advances|January 4, 2018
Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myelomaJerome T Higgs, Joo Hyoung Lee, Hong Wang, et al.
Nano Letters|March 22, 2019
Real-Time Detection of Circulating Tumor Cells in Living Animals Using Functionalized Large Gold NanorodsRebecca Dutta, Orly Liba, Elliott D SoRelle, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|December 9, 2019
Heparanase promotes myeloma stemness and in vivo tumorigenesisKaushlendra Tripathi, Vishnu C Ramani, Shyam K Bandari, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2021
Targeting the tetraspanin CD81 reduces cancer invasion and metastasisFelipe Vences-Catalán, Ranjani Rajapaksa, Chiung-Chi Kuo, et al.
Nature Communications|April 28, 2015
Heparanase is a host enzyme required for herpes simplex virus-1 release from cellsSatvik R Hadigal, Alex M Agelidis, Ghadah A Karasneh, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|February 3, 2012
Heparan sulfate chains of syndecan-1 regulate ectodomain sheddingVishnu C Ramani, Pamela S Pruett, Camilla A Thompson, et al.
Cancer Research|October 28, 2010
Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKLYang Yang, Yongsheng Ren, Vishnu C Ramani, et al.
Oncotarget|December 2, 2015
Targeting heparanase overcomes chemoresistance and diminishes relapse in myelomaVishnu C Ramani, Fenghuang Zhan, Jianbo He, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 27, 2016
Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotypeVishnu C Ramani, Israel Vlodavsky, Mary Ng, et al.
The FEBS Journal|February 5, 2013
The heparanase/syndecan-1 axis in cancer: mechanisms and therapiesVishnu C Ramani, Anurag Purushothaman, Mark D Stewart, et al.
Blood Advances|January 4, 2018
Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myelomaJerome T Higgs, Joo Hyoung Lee, Hong Wang, et al.
Nano Letters|March 22, 2019
Real-Time Detection of Circulating Tumor Cells in Living Animals Using Functionalized Large Gold NanorodsRebecca Dutta, Orly Liba, Elliott D SoRelle, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|December 9, 2019
Heparanase promotes myeloma stemness and in vivo tumorigenesisKaushlendra Tripathi, Vishnu C Ramani, Shyam K Bandari, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2021
Targeting the tetraspanin CD81 reduces cancer invasion and metastasisFelipe Vences-Catalán, Ranjani Rajapaksa, Chiung-Chi Kuo, et al.
Nature Communications|April 28, 2015
Heparanase is a host enzyme required for herpes simplex virus-1 release from cellsSatvik R Hadigal, Alex M Agelidis, Ghadah A Karasneh, et al.
Pageof 3